BACE1 and Alzheimer disease: In contrast, one study [8] reported that metformin could deregulateβ-secretase (BACE1) promoter activity and induce more than twice the normal production ofβ-amyloid peptide (Aβ), the protein that forms toxic brain plaques in Alzheimer's disease (AD).